Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 28, 2011; 17(16): 2063-2069
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2063
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2063
Targeting the cell cycle in esophageal adenocarcinoma: An adjunct to anticancer treatment
Martyn Dibb, Department of Gastroenterology, Royal Albert Edward Infirmary, Wigan Lane, Wigan WN1 2NN, United Kingdom
Yeng S Ang, School of Translational Medicine, Faculty of Medical and Human Sciences, The University of Manchester, Manchester M13 9PL, United Kingdom
Author contributions: Literature review and manuscript by Dibb M, concepts and corrections by Ang YS.
Supported by UK National Institute of Health Research/Cancer Research Network and Research and Development Department of Wrightington Wigan and Leigh NHS Foundation Trust (to Ang YS); Wrightington Wigan and Leigh NHS Foundation Trust Cancer Therapy Fund (to Dibb M)
Correspondence to: Yeng S Ang, MD, FRCP, FRCPI, FEBG, Consultant Gastroenterologist/Honorary Senior Lecturer, Royal Albert Edward Infirmary, Wigan Lane, Wigan WN1 2NN, United Kingdom. yeng.ang@wwl.nhs.uk
Telephone: +44-1942-773119 Fax: +44-1942-822340
Received: December 2, 2010
Revised: January 11, 2011
Accepted: January 18, 2011
Published online: April 28, 2011
Revised: January 11, 2011
Accepted: January 18, 2011
Published online: April 28, 2011
Core Tip